|
 |
5-aminosalicylic acidThis page contains recent news articles, when available, and an overview of 5-aminosalicylic acid but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented the results of three 5-aminosalicylic acid (5-ASA) persistency analyses at ACG ... Reuters Real-World Patient Experiences on Medications for Chronic Conditions ... - Oct 26, 2009 ...perceptions and experiences of patients beginning and continuing a new course of 5-aminosalicylic acid (5-ASA), the mainstay of treatment for UC. ... Reuters Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine ... - Jul 7, 2009 P&GP is also the maker of Asacol(R) (mesalamine) 400 mg delayed-release tablets, the number one most-prescribed oral 5-aminosalicylic acid (5-ASA) therapy. PR Newswire (press release) Grossesse et maladies inflammatoires cryptogénétiques intestinales - Mar 12, 2009 Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroenterol 1988 ; 23 : 1100-4. John Libbey Eurotext FDA Approvals: Apriso, Promacta, Treanda - Dec 4, 2008 ...the product's patented Intellicor delivery system is the first and only to combine delayed and extended release of 5-aminosalicylic acid (5-ASA) — its Medscape Study: 5-ASA Not Useful in Colon Cancer Prevention - Nov 19, 2008 BETHESDA, Md. — Study findings recently published in Clinical Gastroenterology and Hepatology failed to show that the use of 5-aminosalicylic acid (5-ASA) EndoNurse, Cephalon's Treanda OK'd for Second Cancer Indication - Nov 3, 2008 ...a locally acting 5-aminosalicylic acid, to maintain the remission of ulcerative colitis, a chronic inflammatory disease of the colon or large intestine, TMCnet Predictores de recaída de la enfermedad de Crohn - Nov 4, 2008 Controlled trial of oral 5- aminosalicylic acid for the prevention of early relapse in Crohn’s disease. Aliment Pharmacol 1997;11:845–52. 4. Intramed.net (Suscripción), Single-Dose MMX Mesalazine May Be Effective for Ulcerative Colitis - Jun 19, 2008 ..."MMX mesalazine is a once-daily, high-strength (1.2 g/tablet) formulation of 5-aminosalicylic acid [5-ASA]. This study evaluated the safety and efficacy of Medscape (subscription) Alaven Pharmaceutical Introduces Kit for UC Patients - Jun 9, 2008 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987;92(6):1894-1898. RedOrbit, Mesalamine Induces Mucosal Healing in Ulcerative Colitis in ... - May 28, 2008 ...high-strength (1.2 g/tablet) formulation of 5-aminosalicylic acid/mesalamine (marketed as Lialda in the United States, Mezavant XL in the United Kingdom Medscape (subscription) Anti-TNF Therapy for Crohn's Disease: Expert Interview With David ... - May 27, 2008 We know from studies done with 5-aminosalicylic acid in ulcerative colitis that adherence with prescribed treatment is important for maintaining remission. Medscape (subscription) Ajinomoto to Obtain Rights for Colon Ulcer Drug from German Firm - Apr 7, 2008 The drug, 5-aminosalicylic acid, marketed as Salofalk and Granu-Stix by Dr. Falk Pharma in Europe, comes in a form of granulated powder, and only needs to Japan Corporate News (press release), |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
